What's new?

Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk

Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash   Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson   PARIS, France – June 11, 2020 - Sofinnova Partners, a leading European life sciences venture capital firm...

Green chemistry on an industrial scale: AFYREN starts construction of its first factory

Dec. 9, 2020,   AFYREN, a biotechnology start-up that is a member of the French Tech 120, is making the leap to industrial-scale production as it begins construction of a zero-waste, low-carbon factory in France’s Grand Est region.     Responding to the growing desire to cut the use of oil derivatives, AFYREN provi...

CorVent Medical Receives FDA Emergency Use Authorization Of Its Novel RESPOND-19™ Ventilator For Multiple Patient Use

Intuitive critical care respiratory system provides reliable and affordable deployment to treat more patients during surges in clinical demand   NEW YORK, Dec. 8, 2020 /PRNewswire/    CorVent Medical, a Coridea portfolio company focused on developing versatile, reusable, lifesaving ventilators, announced today that...

HOOKIPA Pharma’s LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article

Peer reviewed article in OncoImmunology demonstrates promising preclinical results for the novel cancer therapy targeting Human Papillomavirus 16 (HPV16) E6/E7 HPV is estimated to cause approximately 5% of the worldwide cancer burden     NEW YORK and VIENNA, Austria, Sept. 16, 2020 (GLOBE NEWSWIRE)    HOOKIPA Pharm...

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

December 03, 2020 03:00 AM Eastern Standard Time   MILAN--(BUSINESS WIRE)--   Enthera Pharmaceuticals (“Enthera”), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, anno...

Redx Pharma plc Placing to raise c.£25.5 million and Open Offer to raise up to £2.2 million and Conversion of loan notes

Alderley Park, 2 December 2020 - Redx (AIM: REDX), the drug discovery and development company focused on cancer and fibrosis, announces today that it has conditionally raised c.£25.5 million (before expenses) by way of a placing of 45,603,575 new Ordinary Shares (the "Placing Shares") with both new institutional in...

Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners

In-licensing of four clinical-stage product candidates to treat orphan neurological disorders Highly experienced team leverages latest scientific discoveries in neuroscience Financing will advance the development of four clinical-stage product candidates Strong participation from international syndicate of investor...

Catamaran Bio Launches with $42 Million Financing to Develop Off‑the‑Shelf CAR-NK Cell Therapies to Treat Solid Tumors

Company brings together scientific founders with leading-edge expertise in NK cells and leadership team with deep cell therapy experience   Proceeds to advance two lead CAR-NK cell therapy programs based on the company’s TAILWIND™ Platform   November 23, 2020 07:00 AM Eastern Standard Time   CAMBRIDGE, Mass.--(BUSI...

Pixium Vision receives French regulatory authority (ANSM) approval to initiate European PRIMAvera pivotal study of Prima System

Paris, November 20, 2020 – 07.00 CET– Pixium Vision (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, today announces it has received approval from the French regulatory health auth...

Michelin and Pyrowave Join Forces to Industrialize an Innovative Plastic Waste Recycling Technology

- Michelin Group and the Canadian firm Pyrowave join forces to accelerate time-to-market for an innovative plastic waste recycling technology. - They agree to fast track the process industrialization. - The purpose of the technology is to increase the rate of sustainable materials not only in Michelin tires, but al...

TISSIUM Receives FDA Investigational Device Exemption for Vascular Sealant

IDE Approval Clears Path to U.S. Clinical Trial Launch for Vascular Sealant   TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has received approval from the U.S. Food and Drug Administration for its Investigational Device Exemption...

1 2 3 4 ... 9